Concepedia

Raltegravir-based Prophylaxis

Raltegravir-Based Prophylaxis is a post-exposure prophylactic regimen that belongs to the class of antiretroviral prevention strategies and is distinguished by its inclusion of raltegravir, an integrase strand transfer inhibitor, to block HIV replication following potential exposure.

19

Publications

780

Citations

179

Authors

97

Institutions

Publications per year

2017–2026

8

Parents

Publications

19

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Joseph J. Eron, Jürgen K. Rockstroh, Jacques Reynes et al. · The Lancet Infectious Diseases · 2011 · 191 citations · Full text

, , +8

Oral Pre-Exposure Prophylaxis by Anti-Retrovirals Raltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model

C. Preston Neff, Thomas Ndolo, Apurva Tandon et al. · PLoS ONE · 2010 · 104 citations · Full text

, , +17

Raltegravir, Tenofovir DF, and Emtricitabine for Postexposure Prophylaxis to Prevent the Sexual Transmission of HIV

Kenneth H. Mayer, Matthew J. Mimiaga, Marcy Gelman et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 76 citations

, , +17

Raltegravir‐emtricitabine‐tenofovir as <scp>HIV</scp> nonoccupational post‐exposure prophylaxis in men who have sex with men: safety, tolerability and adherence

John McAllister, Phillip Read, Anna McNulty et al. · HIV Medicine · 2013 · 52 citations

, , +17

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

Esaú João, R. L. Morrison, David E. Shapiro et al. · The Lancet HIV · 2020 · 46 citations · Full text

, , +16

1–5 of 19

Authors

179

  1. MB
    M.S. Barski

    Imperial College London, United Kingdom

    2 publications · 58 citations

    2

    h-index

  2. JJ
    Joseph J. Eron

    University of North Carolina at Chapel Hill, United States

    2 publications · 210 citations

    2

    h-index

  3. GN
    Goedele N. Maertens

    Imperial College London, United Kingdom

    2 publications · 58 citations

    2

    h-index

  4. CK
    Christine Katlama

    Sorbonne Université, France

    2 publications · 210 citations

    2

    h-index

  5. EJ
    Esaú João

    Hospital Federal dos Servidores do Estado, Brazil

    1 publications · 46 citations

    1

    h-index

1–5 of 179

Institutions

97

  1. Harvard University

    Cambridge, United States

    3 h-index

    4 publications

    134 citations

  2. Imperial College London

    London, United Kingdom

    3 h-index

    9 publications

    216 citations

  3. Sorbonne Université

    Paris, France

    2 h-index

    2 publications

    210 citations

  4. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    2 h-index

    15 publications

    2.5K citations

  5. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    2 h-index

    2 publications

    210 citations

  6. University of California San Diego

    San Diego, United States

    2 h-index

    2 publications

    68 citations

  7. Eunice Kennedy Shriver National Institute of Child Health and Human Development

    Bethesda, United States

    2 h-index

    2 publications

    68 citations

  8. Pitié-Salpêtrière Hospital

    Paris, France

    2 h-index

    2 publications

    210 citations

1–8 of 97

Venues

  1. Journal of Antimicrobial Chemotherapy

    JAC · 3 publications · 64 citations

    3

    h-index

  2. 2

    h-index

  3. Malaria Journal

    1 publications · 15 citations

    1

    h-index

  4. International Journal of STD & AIDS

    1 publications · 14 citations

    1

    h-index

  5. The Lancet

    1 publications · 41 citations

    1

    h-index

1–5